Key facts
- It has raised $280K across 1 recorded rounds; the latest was Angel (individual) ($280K) in Jan 2025.
- Notable investors include Matter (Consulting Services (B2B)).
- BioTech Social has filed 2 Form Ds with the SEC, most recently Jan 2025 ($275K sold to 2 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for BioTech Social
Funding rounds
1 roundsAbout BioTech Social
Operator of a funding platform intended for life science startups. The company's platform facilitates access to novel financing methods for biotech, med-tech, pharma-tech, diagnostic, and digital health technology companies, enabling businesses to secure the capital needed for research, development, and growth by connecting them with diverse funding sources and streamlining the investment process.
- Sector
- Financial Services
- HQ
- Rockville, MD, United States
- Founded
- 2021
- Website
- biotech.social/
- Ownership
- Privately Held (backing)
BioTech Social doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioTech Social shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioTech Social in its N-PORT filings yet. We sweep new filings monthly.